The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Acute Liver Failure Treatment Market Research Report 2025
Synopsis
Acute liver failure is a rare condition. It happens when your liver suddenly begins to lose its ability to function. This often happens right after an overdose of medicine or poisoning. For acute (sudden) liver failure, treatment includes: Intravenous (IV) fluids to maintain blood pressure; Medications such as laxatives or enemas to help flush toxins (poisons) out; Blood glucose (sugar) monitoring; glucose is given to the patient if blood sugar drops.
Global Acute Liver Failure Treatment market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Acute Liver Failure Treatment market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Acute Liver Failure Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Novartis AG
Bayer AG
Cardiorentis AG
Cytokinetics, Inc.
Orion Corporation
Bristol-Myers Squibb Company
PhaseBio Pharmaceuticals, InC
Merck & Co
Segment by Type
Hepatocyte Transplantation
Assisted Liver Transplantation
Xenotransplantation
Segment by Application
Hospitals
Clinics
Liver Academic and Research Institutes
Forensic Laboratories
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Acute Liver Failure Treatment report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Acute liver failure is a rare condition. It happens when your liver suddenly begins to lose its ability to function. This often happens right after an overdose of medicine or poisoning. For acute (sudden) liver failure, treatment includes: Intravenous (IV) fluids to maintain blood pressure; Medications such as laxatives or enemas to help flush toxins (poisons) out; Blood glucose (sugar) monitoring; glucose is given to the patient if blood sugar drops.
Global Acute Liver Failure Treatment market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Acute Liver Failure Treatment market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Acute Liver Failure Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Novartis AG
Bayer AG
Cardiorentis AG
Cytokinetics, Inc.
Orion Corporation
Bristol-Myers Squibb Company
PhaseBio Pharmaceuticals, InC
Merck & Co
Segment by Type
Hepatocyte Transplantation
Assisted Liver Transplantation
Xenotransplantation
Segment by Application
Hospitals
Clinics
Liver Academic and Research Institutes
Forensic Laboratories
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Acute Liver Failure Treatment report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acute Liver Failure Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Hepatocyte Transplantation
1.2.3 Assisted Liver Transplantation
1.2.4 Xenotransplantation
1.3 Market by Application
1.3.1 Global Acute Liver Failure Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Liver Academic and Research Institutes
1.3.5 Forensic Laboratories
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Acute Liver Failure Treatment Market Perspective (2018-2029)
2.2 Acute Liver Failure Treatment Growth Trends by Region
2.2.1 Global Acute Liver Failure Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Acute Liver Failure Treatment Historic Market Size by Region (2018-2023)
2.2.3 Acute Liver Failure Treatment Forecasted Market Size by Region (2024-2029)
2.3 Acute Liver Failure Treatment Market Dynamics
2.3.1 Acute Liver Failure Treatment Industry Trends
2.3.2 Acute Liver Failure Treatment Market Drivers
2.3.3 Acute Liver Failure Treatment Market Challenges
2.3.4 Acute Liver Failure Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Acute Liver Failure Treatment Players by Revenue
3.1.1 Global Top Acute Liver Failure Treatment Players by Revenue (2018-2023)
3.1.2 Global Acute Liver Failure Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Acute Liver Failure Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Acute Liver Failure Treatment Revenue
3.4 Global Acute Liver Failure Treatment Market Concentration Ratio
3.4.1 Global Acute Liver Failure Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acute Liver Failure Treatment Revenue in 2022
3.5 Acute Liver Failure Treatment Key Players Head office and Area Served
3.6 Key Players Acute Liver Failure Treatment Product Solution and Service
3.7 Date of Enter into Acute Liver Failure Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Acute Liver Failure Treatment Breakdown Data by Type
4.1 Global Acute Liver Failure Treatment Historic Market Size by Type (2018-2023)
4.2 Global Acute Liver Failure Treatment Forecasted Market Size by Type (2024-2029)
5 Acute Liver Failure Treatment Breakdown Data by Application
5.1 Global Acute Liver Failure Treatment Historic Market Size by Application (2018-2023)
5.2 Global Acute Liver Failure Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Acute Liver Failure Treatment Market Size (2018-2029)
6.2 North America Acute Liver Failure Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Acute Liver Failure Treatment Market Size by Country (2018-2023)
6.4 North America Acute Liver Failure Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Acute Liver Failure Treatment Market Size (2018-2029)
7.2 Europe Acute Liver Failure Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Acute Liver Failure Treatment Market Size by Country (2018-2023)
7.4 Europe Acute Liver Failure Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Acute Liver Failure Treatment Market Size (2018-2029)
8.2 Asia-Pacific Acute Liver Failure Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Acute Liver Failure Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Acute Liver Failure Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Acute Liver Failure Treatment Market Size (2018-2029)
9.2 Latin America Acute Liver Failure Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Acute Liver Failure Treatment Market Size by Country (2018-2023)
9.4 Latin America Acute Liver Failure Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Acute Liver Failure Treatment Market Size (2018-2029)
10.2 Middle East & Africa Acute Liver Failure Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Acute Liver Failure Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Acute Liver Failure Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Detail
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Acute Liver Failure Treatment Introduction
11.1.4 Novartis AG Revenue in Acute Liver Failure Treatment Business (2018-2023)
11.1.5 Novartis AG Recent Development
11.2 Bayer AG
11.2.1 Bayer AG Company Detail
11.2.2 Bayer AG Business Overview
11.2.3 Bayer AG Acute Liver Failure Treatment Introduction
11.2.4 Bayer AG Revenue in Acute Liver Failure Treatment Business (2018-2023)
11.2.5 Bayer AG Recent Development
11.3 Cardiorentis AG
11.3.1 Cardiorentis AG Company Detail
11.3.2 Cardiorentis AG Business Overview
11.3.3 Cardiorentis AG Acute Liver Failure Treatment Introduction
11.3.4 Cardiorentis AG Revenue in Acute Liver Failure Treatment Business (2018-2023)
11.3.5 Cardiorentis AG Recent Development
11.4 Cytokinetics, Inc.
11.4.1 Cytokinetics, Inc. Company Detail
11.4.2 Cytokinetics, Inc. Business Overview
11.4.3 Cytokinetics, Inc. Acute Liver Failure Treatment Introduction
11.4.4 Cytokinetics, Inc. Revenue in Acute Liver Failure Treatment Business (2018-2023)
11.4.5 Cytokinetics, Inc. Recent Development
11.5 Orion Corporation
11.5.1 Orion Corporation Company Detail
11.5.2 Orion Corporation Business Overview
11.5.3 Orion Corporation Acute Liver Failure Treatment Introduction
11.5.4 Orion Corporation Revenue in Acute Liver Failure Treatment Business (2018-2023)
11.5.5 Orion Corporation Recent Development
11.6 Bristol-Myers Squibb Company
11.6.1 Bristol-Myers Squibb Company Company Detail
11.6.2 Bristol-Myers Squibb Company Business Overview
11.6.3 Bristol-Myers Squibb Company Acute Liver Failure Treatment Introduction
11.6.4 Bristol-Myers Squibb Company Revenue in Acute Liver Failure Treatment Business (2018-2023)
11.6.5 Bristol-Myers Squibb Company Recent Development
11.7 PhaseBio Pharmaceuticals, InC
11.7.1 PhaseBio Pharmaceuticals, InC Company Detail
11.7.2 PhaseBio Pharmaceuticals, InC Business Overview
11.7.3 PhaseBio Pharmaceuticals, InC Acute Liver Failure Treatment Introduction
11.7.4 PhaseBio Pharmaceuticals, InC Revenue in Acute Liver Failure Treatment Business (2018-2023)
11.7.5 PhaseBio Pharmaceuticals, InC Recent Development
11.8 Merck & Co
11.8.1 Merck & Co Company Detail
11.8.2 Merck & Co Business Overview
11.8.3 Merck & Co Acute Liver Failure Treatment Introduction
11.8.4 Merck & Co Revenue in Acute Liver Failure Treatment Business (2018-2023)
11.8.5 Merck & Co Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
